Diabetes Pakistan Metabolic Syndrome Date: 1st - 2nd November, 2024 Venue: Serena Hotel, Faisalabad
For Emergencies: +92 41-2694037
Connection between Diabetes and Cognitive Decline

The Connection between Diabetes and Cognitive Decline

Dr. Ahmad Shahzad
Founder | Lyallpur Diabetes Foundation
Consultant Diabetologist | Educator | Advocate for Preventive Care

The effect of diabetes on blood sugar control is well known; however, its effects extend far beyond just physical health. Studies indicate a Connection between Diabetes and Cognitive Decline, attributing the disease to memory loss, diminished attention and even increased dementia susceptibility. This relationship is paramount as it reveals the necessity of controlling diabetes to not only preserve the body but also the health of the brain in the long term.

Understanding Cognitive Decline

Cognitive decline is a progressive loss of mental abilities like memory, reasoning and attention. It is commonly an aging process but may be hastened or aggravated by multiple factors such as illnesses and habits.

Symptoms

Symptoms can vary but often include:

  • Memory loss or trouble recalling recent events.
  • Difficulty finding words or expressing oneself.
  • Getting lost in familiar places.
  • Trouble with concentration and complex tasks.
  • Mood changes such as increased anxiety or irritability.

How Diabetes Affects the Brain

Brain- Diabetes has several serious effects on the brain, including cognitive impairment, memory loss and dementia. Brain dysfunction is caused by both type 1 and type 2 diabetes, but type 2 diabetes is more closely associated with faster brain aging and dementia, such as Alzheimer disease and vascular dementia.

Mechanisms of Brain Impact

  • Diabetes leads to injury of small and large blood vessels in the brain that limits blood flow and oxygen supply to the brain thus affecting the functioning of brain cells leading to stroke and vascular dementia.
  • And high blood sugar (hyperglycemia) and insulin resistance impair brain metabolism. Brain insulin resistance may also change how energy is used and lead to accumulation of harmful proteins (amyloid and tau) that cause Alzheimer disease.
  • There is observed brain atrophy (shrinkage), especially in memory and executive functions such as hippocampus, medial temporal, and frontal lobes in individuals with diabetes.
  • Neuroinflammation and disturbances in the metabolism of neurotransmitters in the brain due to diabetes are other factors that contribute to the neuronal damage and cognitive decline.

Cognitive Effects and Risk

  • Diabetics (type 2) show increased rates of cognitive impairment compared to healthy people; memory, speed of processing, and some executive functions like planning and attention.
  • There are slight variations in brain functions in children with type 1 diabetes that can influence learning and behavior.
  • • The more a person has diabetics and the poorer the blood glucose management, the greater the risk of cognitive impairment and dementia.

Scientific Evidence Linking Diabetes and Cognitive Decline

Scientific Evidence Linking Diabetes and Cognitive Decline

There is strong scientific evidence of the association between diabetes and cognitive impairment, such as, higher risk of dementia and Alzheimer disease. Numerous studies of high quality, systematic reviews and meta-analyses have found this relation based on observational research, neuroimaging and biochemical studies.

Key Evidence and Findings

  • Diabetes worsens cognitive impairment through chronic hyperglycemia, insulin resistance, inflammation, vascular damage, and oxidative stress, which cause brain cell damage and neurodegenerative protein buildup (tau and amyloid-beta).
  • Meta-analyses indicate that individuals with diabetes face an increased risk of getting dementia (59-73 percent higher than non-diabetics) and an almost doubled risk of getting Alzheimer disease.
  • The risk of cognitive loss is increased by diabetes and the occurrence of complications like hypoglycemia.
  • A. Neuroimaging showed accelerated brain atrophy and accelerated cognitive decline in individuals with type 2 diabetes compared to age controls.
  • Mechanistic studies (1) connect neurodegeneration and impaired neurotransmitter balance to diabetes-related brain insulin resistance, mitochondrial dysfunction, and chronic inflammation.
  • Glucose-lowering treatments such as metformin and SGLT-2 inhibitors demonstrate the possibility to decrease dementia risk in diabetic groups, which indicates modifiable aspects in diabetes treatment to reduce cognitive impairment.

Risk Factors and Contributing Elements

Diabetes-related cognitive decline is influenced by multiple risk factors and contributing elements spanning vascular, metabolic, inflammatory, and lifestyle domains.

Major Risk Factors

  • Vascular Disease: Macrovascular (stroke, heart disease) and microvascular (retinopathy, nephropathy) diabetes complicates are significant in terms of cognitive impairment. These risks are worsened by hypertension and dyslipidemia.
  • Hyperglycemia: Persistent elevated blood sugar and glucose levels cause neuronal oxidative stress, mitochondrial dysfunction, and the generation of toxic AGEs, enabling damaging brain inflammation.
  • Hyperinsulinemia and Insulin Resistance: Early insulin resistance and elevated insulin levels are associated with worse cognition and risk of Alzheimer, in part because of impaired brain insulin signaling.
  • Neuroinflammation: The diabetic brain is persistently inflamed with increased levels of inflammatory cytokines and microglial activation leading to neuronal damage resulting in the exacerbation of cognitive impairment.
  • Period and Level of Diabetes: Longer diabetes and high HbA1c decrease the cognitive impairment potential and severity.
  • Other Factors: It is also increased by age (greater than 60 years), female sex, low education level, stroke or depressive history, obesity, smoking and lack of exercise.

Additional Considerations

  • The abnormalities in the brain metabolic markers and neurotransmitters of memory and cognitive processing are usually identified in diabetic patients.
  • Mild cognitive impairment (MCI) is prevalent in older adults with type 2 diabetes, which usually evolves into dementia unless treated.
  • Certain antidiabetic medications such as metformin can protect cognition, but the evidence is inconclusive and needs to be examined further.

You may also like to read: Role of Oxidative Stress in Diabetic Complications

Prevention and Management Strategies

Cognitive decline in diabetes is prevented and managed by maximizing metabolic control, vascular risk factors, and healthy lifestyle behaviors.

Glycemic Control

·       Antidiuretic drugs like metformin and SGLT-2 blockers have demonstrated some neuroprotective effects by risk-reducing dementia and enhancing cognitive performance.

·       Good glucose control is paramount but excessive tight control resulting in a higher risk of hypoglycemia can exacerbate cognition. HbA1c targets are to be individualized depending on cognitive status and age to prevent hypoglycemia.

Cardiovascular and Vascular Risk Management

·       Regular aerobic physical activity is associated with enhanced cardiovascular health, cerebral blood flow, neurotrophic, and inflammation, which in totality safeguard cognition.

·       Management of hypertension, dyslipidemia and other cardiovascular risk factors minimize cerebrovascular loss which causes impairment in cognition.

Lifestyle Interventions

·       Vascular and metabolic health can be supported by a healthy diet, including the Mediterranean diet.

·       Physical activity is one of the most supported methods of preventing age-related cognitive decline and dementia.

·       Cognitive stimulation and socialization are suggested as effective in keeping the brain functioning.

Additional Strategies

  • Prevention of hypoglycemia is vital as it is linked to progressive cognitive impairment and a higher risk of severe events among the cognitively impaired diabetics.
  • Cognitive health is further supported by monitoring and the management of comorbidities such as depression and obesity.
  • Studies of new treatments of brain insulin resistance, inflammation, and amyloid deposition are in progress.

Final Thoughts

Diabetes is also associated with mental degradation, where both biological and lifestyle determinants contribute to the phenomenon. The risks are severe, but the brain can be preserved with proper blood sugar management, healthy lifestyle, and frequent cognitive monitoring. With some proactive measures, people with diabetes can mitigate the risk and help to maintain their physical and psychological health in the long term.